Health Bayer Secures FDA Approval for Hyrnuo to Treat Lung Cancer Bayer AG has received approval from the United States Food and Drug Administration (FDA) for its new drug Hyrnuo, aimed at treating a prevalent... Editorial20 November, 2025
Health Ongoing Trials Enhance Use of CDK4/6 Inhibitors in Breast Cancer The use of CDK4/6 inhibitors remains pivotal in treating hormone receptor (HR)-positive metastatic breast cancer, both HER2-negative and HER2-positive, especially for patients experiencing visceral... Editorial30 August, 2025